{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:59:03Z","timestamp":1792616343994,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jpeds.2022.02.016","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T11:10:14Z","timestamp":1644837014000},"page":"184-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Comparison of Permethrin-Based Treatment Strategies against Scabies in Infants and Young Children"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-9478","authenticated-orcid":false,"given":"Katharina","family":"Riebenbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp B.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Haitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Walochnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Valencak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Meyersburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Kinaciyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9823-7644","authenticated-orcid":false,"given":"Alessandra","family":"Handisurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2022.02.016_bib1","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","article-title":"The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015","volume":"17","author":"Karimkhani","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jpeds.2022.02.016_bib2","first-page":"33","article-title":"Scabies: a neglected global disease","volume":"16","author":"Leung","year":"2020","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.jpeds.2022.02.016_bib3","doi-asserted-by":"crossref","first-page":"2020-12-3","DOI":"10.7573\/dic.2020-12-3","article-title":"Paediatrics: how to manage scabies","volume":"10","author":"Thompson","year":"2021","journal-title":"Drugs Context"},{"key":"10.1016\/j.jpeds.2022.02.016_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMct0910329","article-title":"Permethrin and ivermectin for scabies","volume":"362","author":"Currie","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2022.02.016_bib5","doi-asserted-by":"crossref","first-page":"e910","DOI":"10.1542\/peds.2013-2880","article-title":"Clinical phenotype of scabies by age","volume":"133","author":"Boralevi","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2022.02.016_bib6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/pde.13255","article-title":"Scabies in babies","volume":"34","author":"Hill","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaad.2019.01.004","article-title":"Efficacy and safety of antiscabietic agents: a systematic review and network meta-analysis of randomized controlled trials","volume":"80","author":"Thadanipon","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib8","first-page":"1707","article-title":"Scabies","volume":"2014","author":"Johnstone","year":"2014","journal-title":"BMJ Clin Evid"},{"key":"10.1016\/j.jpeds.2022.02.016_bib9","doi-asserted-by":"crossref","first-page":"e13746","DOI":"10.1111\/dth.13746","article-title":"Scabies: a comprehensive review and current perspectives","volume":"33","author":"Arora","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jpeds.2022.02.016_bib10","doi-asserted-by":"crossref","first-page":"F184","DOI":"10.1136\/adc.2002.024927","article-title":"Probable adverse reaction to a pharmaceutical excipient","volume":"89","author":"Hall","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jpeds.2022.02.016_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4269\/ajtmh.17-0042","article-title":"Serious neurological adverse events after ivermectin\u2014do they occur beyond the indication of onchocerciasis?","volume":"98","author":"Chandler","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jpeds.2022.02.016_bib12","doi-asserted-by":"crossref","first-page":"e0005920","DOI":"10.1371\/journal.pntd.0005920","article-title":"Scabies in the age of increasing drug resistance","volume":"11","author":"Khalil","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jpeds.2022.02.016_bib13","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(06)68772-2","article-title":"Scabies","volume":"367","author":"Heukelbach","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2022.02.016_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/ajd.13654","article-title":"A narrative review of the roles of topical permethrin and oral ivermectin in the management of infantile scabies","volume":"62","author":"Lobo","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.14351","article-title":"European guideline for the management of scabies","volume":"31","author":"Salavastru","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/ddg.13130","article-title":"S1 guidelines on the diagnosis and treatment of scabies\u2014short version","volume":"14","author":"Sunderk\u00f6tter","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jpeds.2022.02.016_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/bjd.18943","article-title":"The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies","volume":"183","author":"Engelman","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1525-1470.2009.00973.x","article-title":"Infant skin microstructure assessed in\u00a0vivo differs from adult skin in organization and at the cellular level","volume":"27","author":"Stamatas","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib19","first-page":"597","article-title":"Topical scabies therapy with permethrin is effective and well tolerated in infants younger than two months","volume":"17","author":"Hoffmann","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jpeds.2022.02.016_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/17460913.3.1.57","article-title":"Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance","volume":"3","author":"Mounsey","year":"2008","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib22","first-page":"1","article-title":"\u2018Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study\u2019","author":"Meyersburg","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jpeds.2022.02.016_bib23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00105-020-04608-0","article-title":"Increase of scabies and therapy resistance among German military personnel: an 8-year follow-up study in the Department of Dermatology of the Armed Forces Hospital Berlin, Germany (2012-2019)","volume":"71","author":"Elsner","year":"2020","journal-title":"Hautarzt"},{"key":"10.1016\/j.jpeds.2022.02.016_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00105-020-04561-y","article-title":"Scabies therapy in Germany : Results of a nationwide survey with a special focus on the efficacy of first-line therapy with permethrin","volume":"71","author":"Hackenberg","year":"2020","journal-title":"Hautarzt"},{"key":"10.1016\/j.jpeds.2022.02.016_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2915.2008.00716.x","article-title":"High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites","volume":"22","author":"Pasay","year":"2008","journal-title":"Med Vet Entomol"},{"issue":"suppl 3","key":"10.1016\/j.jpeds.2022.02.016_bib26","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1093\/infdis\/jiu232","article-title":"Sex differences in pediatric infectious diseases","volume":"209","author":"Muenchhoff","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2022.02.016_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/ije\/21.2.381","article-title":"The male predominance in the incidence of infectious diseases in children: q postulated explanation for disparities in the literature","volume":"21","author":"Green","year":"1992","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib28","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.rmed.2007.04.011","article-title":"Sex differences in the incidence and severity of respiratory tract infections","volume":"101","author":"Falagas","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.jpeds.2022.02.016_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2019.11.002","article-title":"Skin thickness measurements for optimal intradermal injections in children","volume":"38","author":"Van Mulder","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2022.02.016_bib31","doi-asserted-by":"crossref","first-page":"e00381-17","DOI":"10.1128\/AAC.00381-17","article-title":"In\u00a0vitro efficacy of moxidectin versus ivermectin against Sarcoptes scabiei","volume":"61","author":"Mounsey","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jpeds.2022.02.016_bib32","doi-asserted-by":"crossref","first-page":"e0005030","DOI":"10.1371\/journal.pntd.0005030","article-title":"Preclinical study of single-dose moxidectin, a new oral treatment for scabies: efficacy, safety, and pharmacokinetics compared to two-dose ivermectin in a porcine model","volume":"10","author":"Bernigaud","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jpeds.2022.02.016_bib33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bjd.18369","article-title":"Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study","volume":"182","author":"Levy","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/archdischild-2017-314505","article-title":"Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?","volume":"103","author":"Wilkins","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2022.02.016_bib35","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1111\/jdv.16554","article-title":"Effectiveness and adverse events of ivermectin treatment for scabies in 30 infant patients: report from a German single centre","volume":"34","author":"St\u00e4nder","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jpeds.2022.02.016_bib36","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/bjd.12454","article-title":"Treatment of scabies with oral ivermectin in 15 infants: a retrospective study on tolerance and efficacy","volume":"169","author":"B\u00e9court","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347622001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347622001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:11:40Z","timestamp":1758359500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347622001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":34,"alternative-id":["S0022347622001159"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2022.02.016","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Permethrin-Based Treatment Strategies against Scabies in Infants and Young Children","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2022.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}